{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:49:48Z","timestamp":1793713788129,"version":"4.6.1"},"reference-count":149,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.biopsych.2014.05.006","type":"journal-article","created":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T17:30:18Z","timestamp":1400347818000},"page":"43-51","source":"Crossref","is-referenced-by-count":1292,"title":["Alzheimer\u2019s Disease Risk Genes and Mechanisms of Disease Pathogenesis"],"prefix":"10.1016","volume":"77","author":[{"given":"Celeste M.","family":"Karch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Goate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2014.05.006_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2014.05.006_bib2","doi-asserted-by":"crossref","first-page":"77sr71","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer\u2019s disease: The challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biopsych.2014.05.006_bib3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2014.05.006_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2014.05.006_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2014.05.006_bib6","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2014.05.006_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","article-title":"Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE","volume":"83","author":"Bertram","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2014.05.006_bib8","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1093\/hmg\/ddp323","article-title":"Potential late-onset Alzheimer\u2019s disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity","volume":"18","author":"Kim","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2014.05.006_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2014.05.006_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2014.05.006_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature12825","article-title":"Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer\u2019s disease","volume":"505","author":"Cruchaga","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2014.05.006_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","article-title":"Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease","volume":"153","author":"Zhang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2014.05.006_bib13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2014.05.006_bib14","doi-asserted-by":"crossref","first-page":"e1001101","DOI":"10.1371\/journal.pgen.1001101","article-title":"SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer\u2019s disease","volume":"6","author":"Cruchaga","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1016\/j.biopsych.2014.05.006_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuron.2013.02.026","article-title":"GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer\u2019s disease","volume":"78","author":"Cruchaga","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2014.05.006_bib16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3233\/JAD-2010-091711","article-title":"Validating predicted biological effects of Alzheimer\u2019s disease associated SNPs using CSF biomarker levels","volume":"21","author":"Kauwe","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2014.05.006_bib17","doi-asserted-by":"crossref","first-page":"e15918","DOI":"10.1371\/journal.pone.0015918","article-title":"Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer\u2019s disease","volume":"6","author":"Kauwe","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2014.05.006_bib18","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1073\/pnas.0801227105","article-title":"Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition","volume":"105","author":"Kauwe","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.05.006_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archneurol.2010.108","article-title":"Genetic variation and neuroimaging measures in Alzheimer disease","volume":"67","author":"Biffi","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib20","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jamaneurol.2013.2815","article-title":"Genetic susceptibility for Alzheimer disease neuritic plaque pathology","volume":"70","author":"Shulman","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib21","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.jalz.2013.05.1769","article-title":"The Alzheimer\u2019s Disease Neuroimaging Initiative: A review of papers published since its inception","volume":"9","author":"Weiner","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2014.05.006_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neurobiolaging.2010.03.025","article-title":"The genetic architecture of Alzheimer\u2019s disease: Beyond APP, PSENs and APOE","volume":"33","author":"Guerreiro","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2014.05.006_bib23","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.R800019200","article-title":"Amyloid precursor protein trafficking, processing, and function","volume":"283","author":"Thinakaran","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2014.05.006_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0896-6273(93)90315-I","article-title":"Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein","volume":"10","author":"Mattson","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2014.05.006_bib25","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1523\/JNEUROSCI.1026-07.2007","article-title":"The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice","volume":"27","author":"Ring","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.05.006_bib26","doi-asserted-by":"crossref","first-page":"e31039","DOI":"10.1371\/journal.pone.0031039","article-title":"Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer\u2019s disease families","volume":"7","author":"Cruchaga","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2014.05.006_bib27","doi-asserted-by":"crossref","first-page":"e1003685","DOI":"10.1371\/journal.pgen.1003685","article-title":"The PSEN1, p.E318G variant increases the risk of Alzheimer\u2019s disease in APOE-epsilon4 carriers","volume":"9","author":"Benitez","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.biopsych.2014.05.006_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/alzrt137","article-title":"Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer\u2019s disease Ibero-American cohort","volume":"4","author":"Jin","year":"2012","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.biopsych.2014.05.006_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2014.05.006_bib30","first-page":"3020","article-title":"ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons","volume":"29","author":"Kuhn","year":"2010"},{"key":"10.1016\/j.biopsych.2014.05.006_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neuron.2013.08.035","article-title":"ADAM10 missense mutations potentiate beta-amyloid accumulation by impairing prodomain chaperone function","volume":"80","author":"Suh","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2014.05.006_bib32","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2014.05.006_bib33","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.05.006_bib34","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2014.05.006_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer\u2019s disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2014.05.006_bib36","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biopsych.2014.05.006_bib37","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE\/Abeta association in physiological conditions","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.05.006_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","article-title":"Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition","volume":"17","author":"Bales","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2014.05.006_bib39","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","article-title":"Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model","volume":"25","author":"Fryer","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.05.006_bib40","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.05.006_bib41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","article-title":"Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer\u2019s disease","volume":"9","author":"Fagan","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2014.05.006_bib42","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","article-title":"Apolipoprotein E in sporadic Alzheimer\u2019s disease: Allelic variation and receptor interactions","volume":"11","author":"Rebeck","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2014.05.006_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib44","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.05.006_bib45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1357-2725(01)00155-8","article-title":"Clusterin","volume":"34","author":"Jones","year":"2002","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib46","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jcp.21671","article-title":"Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells","volume":"219","author":"Rizzi","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib47","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1038\/tp.2011.17","article-title":"Alzheimer\u2019s risk variants in the clusterin gene are associated with alternative splicing","author":"Szymanski","year":"2011","journal-title":"Transl Psychiatry 1.pii"},{"key":"10.1016\/j.biopsych.2014.05.006_bib48","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JAD-2011-111844","article-title":"Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer\u2019s disease","volume":"29","author":"Xing","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2014.05.006_bib49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-2011-110251","article-title":"Association of the Alzheimer\u2019s disease clusterin risk allele with plasma clusterin concentration","volume":"25","author":"Schurmann","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2014.05.006_bib50","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","article-title":"Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease","volume":"67","author":"Thambisetty","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.05.006_bib51","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.2011.381","article-title":"Plasma clusterin and the risk of Alzheimer disease","volume":"305","author":"Schrijvers","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2014.05.006_bib52","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JAD-130380","article-title":"Candidate blood proteome markers of Alzheimer\u2019s disease onset and progression: A systematic review and replication study","volume":"38","author":"Kiddle","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2014.05.006_bib53","doi-asserted-by":"crossref","first-page":"e50976","DOI":"10.1371\/journal.pone.0050976","article-title":"Expression of novel Alzheimer\u2019s disease risk genes in control and Alzheimer\u2019s disease brains","volume":"7","author":"Karch","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2014.05.006_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1212\/WNL.0b013e3182605801","article-title":"Novel late-onset Alzheimer disease loci variants associate with brain gene expression","volume":"79","author":"Allen","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2014.05.006_bib55","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0896-6273(90)90342-D","article-title":"Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer\u2019s disease and in response to experimental lesions in rat","volume":"5","author":"May","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2014.05.006_bib56","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L","article-title":"Apolipoprotein J (clusterin) and Alzheimer\u2019s disease","volume":"50","author":"Calero","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.biopsych.2014.05.006_bib57","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1074\/jbc.270.13.7563","article-title":"Characterization of apolipoprotein J-Alzheimer\u2019s A beta interaction","volume":"270","author":"Matsubara","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2014.05.006_bib58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/exnr.1995.1080","article-title":"Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress","volume":"136","author":"Oda","year":"1995","journal-title":"Exp Neurol"},{"issue":"pt 2","key":"10.1016\/j.biopsych.2014.05.006_bib59","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/bj3160671","article-title":"Apolipoprotein J and Alzheimer\u2019s amyloid beta solubility","volume":"316","author":"Matsubara","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.biopsych.2014.05.006_bib60","doi-asserted-by":"crossref","first-page":"10843","DOI":"10.1073\/pnas.162228299","article-title":"Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer\u2019s disease","volume":"99","author":"Demattos","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.05.006_bib61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","article-title":"ApoE and clusterin cooperatively suppress Abeta levels and deposition: Evidence that ApoE regulates extracellular Abeta metabolism in vivo","volume":"41","author":"DeMattos","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2014.05.006_bib62","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1471-4159.2007.05099.x","article-title":"Role of ATP-binding cassette transporters in brain lipid transport and neurological disease","volume":"104","author":"Kim","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2014.05.006_bib63","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2003.10.002","article-title":"Posttranscriptional regulation of human ABCA7 and its function for the apoA-I-dependent lipid release","volume":"311","author":"Ikeda","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biopsych.2014.05.006_bib64","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2013.09.058","article-title":"ABCA7 expression is associated with Alzheimer\u2019s disease polymorphism and disease status","volume":"556","author":"Vasquez","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2014.05.006_bib65","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/01.wnr.0000221833.41340.cd","article-title":"Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells","volume":"17","author":"Kim","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2014.05.006_bib66","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1074\/jbc.M412602200","article-title":"Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels","volume":"280","author":"Kim","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2014.05.006_bib67","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1523\/JNEUROSCI.4165-12.2013","article-title":"Deletion of Abca7 increases cerebral amyloid-beta accumulation in the J20 mouse model of Alzheimer\u2019s disease","volume":"33","author":"Kim","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.05.006_bib68","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1471-4159.2008.05433.x","article-title":"ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro","volume":"106","author":"Chan","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2014.05.006_bib69","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.200601030","article-title":"ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages","volume":"174","author":"Jehle","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.atherosclerosis.2011.06.031","article-title":"HMG-CoA reductase inhibitors enhance phagocytosis by upregulating ATP-binding cassette transporter A7","volume":"217","author":"Tanaka","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopsych.2014.05.006_bib71","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5551\/jat.6726","article-title":"Roles of ATP-binding cassette transporter A7 in cholesterol homeostasis and host defense system","volume":"18","author":"Tanaka","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.biopsych.2014.05.006_bib72","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/alzrt187","article-title":"Evidence for impaired amyloid beta clearance in Alzheimer\u2019s disease","volume":"5","author":"Wildsmith","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.biopsych.2014.05.006_bib73","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1471-4914(02)02419-X","article-title":"Human complement receptor type 1 (CR1) binds to a major malarial adhesin","volume":"8","author":"Krych-Goldberg","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.biopsych.2014.05.006_bib74","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/08923970902845768","article-title":"The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1\/CD35)","volume":"31","author":"Liu","year":"2009","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib75","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00685397","article-title":"Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study","volume":"57","author":"Eikelenboom","year":"1982","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib76","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0006-8993(97)00850-0","article-title":"Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain","volume":"769","author":"Shen","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2014.05.006_bib77","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0006-8993(97)00849-4","article-title":"Neurons express proteins of the classical complement pathway in Alzheimer disease","volume":"769","author":"Terai","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2014.05.006_bib78","doi-asserted-by":"crossref","first-page":"25068","DOI":"10.1016\/S0021-9258(19)74572-4","article-title":"Expression of the complement classical pathway by human glioma in culture. A model for complement expression by nerve cells","volume":"268","author":"Gasque","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2014.05.006_bib79","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/glia.10234","article-title":"Expression of complement messenger RNAs and proteins by human oligodendroglial cells","volume":"42","author":"Hosokawa","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.biopsych.2014.05.006_bib80","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0304-3940(89)90843-4","article-title":"Activation of the classical complement pathway in brain tissue of Alzheimer patients","volume":"107","author":"McGeer","year":"1989","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2014.05.006_bib81","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3940(01)01842-0","article-title":"Complement activation by neurofibrillary tangles in Alzheimer\u2019s disease","volume":"305","author":"Shen","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2014.05.006_bib82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000463068","article-title":"Two isotypes of human C4, C4A and C4B have different structure and function","volume":"6","author":"Schifferli","year":"1989","journal-title":"Complement Inflamm"},{"key":"10.1016\/j.biopsych.2014.05.006_bib83","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/clin.1994.1017","article-title":"Relationship between immune complex binding and release and the quantitative expression of the complement receptor, type 1 (CR1, CD35) on human erythrocytes","volume":"70","author":"Gibson","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib84","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.neurobiolaging.2005.09.043","article-title":"Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes","volume":"27","author":"Rogers","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2014.05.006_bib85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nm0197-77","article-title":"Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer\u2019s disease pathogenesis","volume":"3","author":"Velazquez","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2014.05.006_bib86","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1023\/A:1018588526788","article-title":"The potential role of sialoadhesin as a macrophage recognition molecule in health and disease","volume":"14","author":"Crocker","year":"1997","journal-title":"Glycoconj J"},{"key":"10.1016\/j.biopsych.2014.05.006_bib87","doi-asserted-by":"crossref","first-page":"13320","DOI":"10.1523\/JNEUROSCI.1224-13.2013","article-title":"CD33 Alzheimer\u2019s risk-altering polymorphism, CD33 expression, and exon 2 splicing","volume":"33","author":"Malik","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.05.006_bib88","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2014.05.006_bib89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/glia.22359","article-title":"Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx","volume":"61","author":"Linnartz","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.biopsych.2014.05.006_bib90","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1128\/MCB.00383-07","article-title":"Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity","volume":"27","author":"Tateno","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib91","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.4049\/jimmunol.0901070","article-title":"MS4A4B is a GITR-associated membrane adapter, expressed by regulatory T cells, which modulates T cell activation","volume":"183","author":"Howie","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib92","doi-asserted-by":"crossref","first-page":"e9369","DOI":"10.1371\/journal.pone.0009369","article-title":"Phylogenetic analysis of the MS4A and TMEM176 gene families","volume":"5","author":"Zuccolo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2014.05.006_bib93","doi-asserted-by":"crossref","first-page":"860959","DOI":"10.1155\/2013\/860959","article-title":"The triggering receptor expressed on myeloid cells 2: \u201cTREM-ming\u201d the inflammatory component associated with Alzheimer\u2019s disease","volume":"2013","author":"Rohn","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.biopsych.2014.05.006_bib94","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nri1106","article-title":"TREMs in the immune system and beyond","volume":"3","author":"Colonna","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib95","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/342259","article-title":"Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype","volume":"71","author":"Paloneva","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2014.05.006_bib96","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","article-title":"Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement","volume":"70","author":"Guerreiro","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib97","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.neurobiolaging.2013.02.016","article-title":"Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer\u2019s disease","volume":"34","author":"Giraldo","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2014.05.006_bib98","first-page":"1565","article-title":"TREM2 and neurodegenerative disease","volume":"369","author":"Bertram","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2014.05.006_bib99","first-page":"1567","article-title":"TREM2 and neurodegenerative disease","volume":"369","author":"Benitez","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2014.05.006_bib100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-122311","article-title":"TREM2 R47H variant as a risk factor for early-onset Alzheimer\u2019s disease","volume":"35","author":"Pottier","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2014.05.006_bib101","first-page":"1569","article-title":"TREM2 and neurodegenerative disease","volume":"369","author":"Guerreiro","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2014.05.006_bib102","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-8-19","article-title":"TREM2 in neurodegeneration: Evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson\u2019s disease","volume":"8","author":"Rayaprolu","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.biopsych.2014.05.006_bib103","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamaneurol.2013.6237","article-title":"TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis","volume":"71","author":"Cady","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib104","first-page":"1565","article-title":"TREM2 and neurodegenerative disease","volume":"369","author":"Rajagopalan","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2014.05.006_bib105","doi-asserted-by":"crossref","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","article-title":"Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) by ectodomain shedding and gamma-secretase dependent intramembranous cleavage","volume":"288","author":"Wunderlich","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2014.05.006_bib106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/MMBR.70.1.37-120.2006","article-title":"The BAR domain proteins: Molding membranes in fission, fusion, and phagy","volume":"70","author":"Ren","year":"2006","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.biopsych.2014.05.006_bib107","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1046\/j.1471-4159.1998.70062369.x","article-title":"Multiple amphiphysin II splice variants display differential clathrin binding: Identification of two distinct clathrin-binding sites","volume":"70","author":"Ramjaun","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2014.05.006_bib108","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0014-5793(97)00928-9","article-title":"Clathrin interacts specifically with amphiphysin and is displaced by dynamin","volume":"413","author":"McMahon","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biopsych.2014.05.006_bib109","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/bbrc.1997.6927","article-title":"cDNA cloning of a novel amphiphysin isoform and tissue-specific expression of its multiple splice variants","volume":"236","author":"Tsutsui","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biopsych.2014.05.006_bib110","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/mp.2013.1","article-title":"Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology","volume":"18","author":"Chapuis","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.05.006_bib111","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.neuroscience.2008.04.012","article-title":"Comparative proteomic analysis of brains of naturally aging mice","volume":"154","author":"Yang","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2014.05.006_bib112","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejcb.2008.08.006","article-title":"The membrane-tubulating potential of amphiphysin 2\/BIN1 is dependent on the microtubule-binding cytoplasmic linker protein 170 (CLIP-170)","volume":"88","author":"Meunier","year":"2009","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib113","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/ncb1986","article-title":"AMPH-1\/Amphiphysin\/Bin1 functions with RME-1\/Ehd1 in endocytic recycling","volume":"11","author":"Pant","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib114","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0166-2236(98)01264-8","article-title":"The amphiphysin family of proteins and their role in endocytosis at the synapse","volume":"21","author":"Wigge","year":"1998","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2014.05.006_bib115","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0896-6273(02)00601-3","article-title":"Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice","volume":"33","author":"Di Paolo","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2014.05.006_bib116","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1097-4644(19990901)74:3<313::AID-JCB1>3.0.CO;2-Z","article-title":"Induction of apoptosis and differentiation in neuroblastoma and astrocytoma cells by the overexpression of Bin1, a novel Myc interacting protein","volume":"74","author":"Galderisi","year":"1999","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.biopsych.2014.05.006_bib117","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cell.2007.12.032","article-title":"Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7","volume":"132","author":"Wajapeyee","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2014.05.006_bib118","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0014-5793(99)00151-9","article-title":"Identification of novel interaction partners for the conserved membrane proximal region of alpha-integrin cytoplasmic domains","volume":"445","author":"Wixler","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biopsych.2014.05.006_bib119","doi-asserted-by":"crossref","first-page":"21279","DOI":"10.1074\/jbc.M111.338376","article-title":"Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis","volume":"287","author":"Xiao","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2014.05.006_bib120","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/NEN.0b013e3181f52e01","article-title":"Distribution and expression of picalm in Alzheimer disease","volume":"69","author":"Baig","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib121","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0854.2007.00694.x","article-title":"Evidence for CALM in directing VAMP2 trafficking","volume":"9","author":"Harel","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.biopsych.2014.05.006_bib122","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0955-0674(98)80067-7","article-title":"Protein traffic in the yeast endocytic and vacuolar protein sorting pathways","volume":"10","author":"Wendland","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib123","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0896-6273(00)80664-9","article-title":"Synaptic vesicle size and number are regulated by a clathrin adaptor protein required for endocytosis","volume":"21","author":"Zhang","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2014.05.006_bib124","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cell.2010.08.014","article-title":"Iron-export ferroxidase activity of \u03b2-amyloid precursor protein is inhibited by zinc in Alzheimer\u2019s disease","volume":"142","author":"Duce","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2014.05.006_bib125","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1126\/science.1213210","article-title":"Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer\u2019s disease risk factors in yeast","volume":"334","author":"Treusch","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2014.05.006_bib126","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1073\/pnas.1315110110","article-title":"Adaptor complex AP2\/PICALM, through interaction with LC3, targets Alzheimer\u2019s APP-CTF for terminal degradation via autophagy","volume":"110","author":"Tian","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.05.006_bib127","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0092-8674(00)81608-6","article-title":"A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts","volume":"94","author":"Dustin","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2014.05.006_bib128","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ajhg.2011.01.006","article-title":"Functional screening of Alzheimer pathology genome-wide association signals in Drosophila","volume":"88","author":"Shulman","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2014.05.006_bib129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-0854.2003.40205.x","article-title":"CD2AP\/CMS regulates endosome morphology and traffic to the degradative pathway through its interaction with Rab4 and c-Cbl","volume":"4","author":"Cormont","year":"2003","journal-title":"Traffic"},{"key":"10.1016\/j.biopsych.2014.05.006_bib130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1242\/jcs.036467","article-title":"EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility","volume":"122","author":"Yamazaki","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.biopsych.2014.05.006_bib131","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neuroscience.2005.06.052","article-title":"Disruption of ephrin-A\/EphA binding alters synaptogenesis and neural connectivity in the hippocampus","volume":"135","author":"Martinez","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2014.05.006_bib132","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.conb.2009.04.009","article-title":"Synapse development and plasticity: Roles of ephrin\/Eph receptor signaling","volume":"19","author":"Lai","year":"2009","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib133","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/147323001103900220","article-title":"Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells","volume":"39","author":"Sakamoto","year":"2011","journal-title":"J Int Med Res"},{"key":"10.1016\/j.biopsych.2014.05.006_bib134","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1943","article-title":"The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease","volume":"39","author":"Rogaeva","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2014.05.006_bib135","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1212\/01.wnl.0000280581.39755.89","article-title":"Association between genetic variants in SORL1 and autopsy-confirmed Alzheimer disease","volume":"70","author":"Lee","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2014.05.006_bib136","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1523\/JNEUROSCI.3882-05.2006","article-title":"Interaction of the cytosolic domains of sorLA\/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme","volume":"26","author":"Spoelgen","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.05.006_bib137","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1523\/JNEUROSCI.4946-05.2006","article-title":"The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments","volume":"26","author":"Offe","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.05.006_bib138","doi-asserted-by":"crossref","first-page":"32956","DOI":"10.1074\/jbc.M705073200","article-title":"SorLA\/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1","volume":"282","author":"Schmidt","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2014.05.006_bib139","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1523\/JNEUROSCI.4582-08.2008","article-title":"Loss of LR11\/SORLA enhances early pathology in a mouse model of amyloidosis: Evidence for a proximal role in Alzheimer\u2019s disease","volume":"28","author":"Dodson","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.05.006_bib140","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/archneur.61.8.1200","article-title":"Loss of apolipoprotein E receptor LR11 in Alzheimer disease","volume":"61","author":"Scherzer","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib141","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/01.jnen.0000228205.19915.20","article-title":"LR11\/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease","volume":"65","author":"Dodson","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib142","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ana.21190","article-title":"Neuronal LR11\/sorLA expression is reduced in mild cognitive impairment","volume":"62","author":"Sager","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib143","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1111\/j.1742-4658.2005.04601.x","article-title":"Hu-K4 is a ubiquitously expressed type 2 transmembrane protein associated with the endoplasmic reticulum","volume":"272","author":"Munck","year":"2005","journal-title":"FEBS J"},{"key":"10.1016\/j.biopsych.2014.05.006_bib144","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1139\/o03-079","article-title":"Phospholipase D","volume":"82","author":"McDermott","year":"2004","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.biopsych.2014.05.006_bib145","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1073\/pnas.0510710103","article-title":"Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer\u2019s disease-linked presenilin-1 mutant neurons","volume":"103","author":"Cai","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.05.006_bib146","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1073\/pnas.0510708103","article-title":"Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation","volume":"103","author":"Cai","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.05.006_bib147","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neurobiolaging.2006.05.022","article-title":"Phospholipase D1 is associated with amyloid precursor protein in Alzheimer\u2019s disease","volume":"28","author":"Jin","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2014.05.006_bib148","doi-asserted-by":"crossref","first-page":"16419","DOI":"10.1523\/JNEUROSCI.3317-10.2010","article-title":"Phospholipase d2 ablation ameliorates Alzheimer\u2019s disease-linked synaptic dysfunction and cognitive deficits","volume":"30","author":"Oliveira","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.05.006_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2013.10.037","article-title":"SnapShot: Genetics of Alzheimer\u2019s disease","volume":"155","author":"Guerreiro","year":"2013","journal-title":"Cell"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322314003394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322314003394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T19:27:48Z","timestamp":1746214068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322314003394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0006322314003394"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2014.05.006","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}